Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Achondroplasia on Quality of Life, Healthcare Resource Use, Clinical, Socio-economic and Psychosocial State of the Individual.

NCT03449368 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.

NCT NCT03449368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03449368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Achondroplasia on Quality of Life, Healthcare Resource Use, Clinical, Socio-economic and Psychosocial State of the Individual.
Lead sponsor
BioMarin Pharmaceutical
Phase
Observational
Overall status
Completed
Start date
December 17, 2017
Completion date
April 29, 2020
Enrollment
196 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

achondroplasia